Can nanoparticles give an old iron chelator a new life? — Development of targeted polymeric nanoparticles with long half-lives to treat iron overload diseases

点击翻译按钮获取中文摘要

Iron loading disorders (such as thalassaemia) represent an important class of human disease. As part of the treatment for these diseases, the iron needs to be removed and this is often done using iron-binding drugs known as iron chelators. Current chelators are not ideal due to side effects or onerous delivery methods. The goal of this project is to use nanotechnology to develop more effective ways of delivering chelators to improve their effectiveness and reduce toxicity.